A detailed history of Franklin Resources Inc transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 67,289 shares of YMAB stock, worth $711,244. This represents 0.0% of its overall portfolio holdings.

Number of Shares
67,289
Previous 67,289 -0.0%
Holding current value
$711,244
Previous $883,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$9.95 - $15.39 $3,104 - $4,801
312 Added 0.47%
67,289 $883,000
Q2 2024

Aug 14, 2024

BUY
$11.6 - $17.25 $394,353 - $586,431
33,996 Added 103.08%
66,977 $809,000
Q1 2024

May 13, 2024

BUY
$6.57 - $18.69 $113,286 - $322,271
17,243 Added 109.56%
32,981 $536,000
Q4 2023

Feb 09, 2024

BUY
$4.88 - $7.42 $287 - $437
59 Added 0.38%
15,738 $107,000
Q3 2023

Nov 13, 2023

SELL
$4.86 - $7.23 $105,884 - $157,520
-21,787 Reduced 58.15%
15,679 $85,000
Q2 2023

Aug 11, 2023

BUY
$5.68 - $10.34 $212,806 - $387,398
37,466 New
37,466 $254,000

Others Institutions Holding YMAB

About Y-mAbs Therapeutics, Inc.


  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $462M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.